As of 2026-04-03, the Relative Valuation of Akoya Biosciences Inc (AKYA) is (21.82) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.29 USD, the upside of Akoya Biosciences Inc based on Relative Valuation is -1791.1%.
The range of the Relative Valuation is (21.22) - (22.44) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.3x - 26.1x | 24.1x |
| Forward P/E multiples | 20.1x - 23.6x | 21.8x |
| Fair Price | (21.22) - (22.44) | (21.82) |
| Upside | -1745.0% - -1839.5% | -1791.1% |
| Date | P/E |